PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Envoy Medical Inc. (COCH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$26.39M
EPS-$1.97
Revenue (TTM)$241.00K
Gross Profit (TTM)-$720.00K
EBITDA (TTM)-$14.43M
Year Range$0.75 - $11.72
Target Price$4.00
Short Ratio0.19

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Envoy Medical Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Envoy Medical Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%December2024FebruaryMarchAprilMay
-68.14%
25.92%
COCH (Envoy Medical Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Envoy Medical Inc. had a return of 71.73% year-to-date (YTD) and -69.27% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date71.73%11.18%
1 month-43.76%5.60%
6 months241.76%17.48%
1 year-69.27%26.33%
5 years (annualized)N/A13.16%
10 years (annualized)N/A10.99%

Monthly Returns

The table below presents the monthly returns of COCH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-35.95%306.03%-16.77%8.42%71.73%
20230.60%-1.09%0.80%-0.30%0.90%1.29%0.68%0.87%-32.55%-82.61%84.43%-19.51%-81.93%
2022-0.51%0.31%0.51%0.31%-0.31%0.31%0.20%0.10%-0.10%0.92%0.71%0.40%2.87%
2021-0.10%-0.72%0.54%-0.84%0.21%0.43%0.29%-0.00%0.00%-0.20%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of COCH is 32, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of COCH is 3232
COCH (Envoy Medical Inc.)
The Sharpe Ratio Rank of COCH is 2929Sharpe Ratio Rank
The Sortino Ratio Rank of COCH is 5555Sortino Ratio Rank
The Omega Ratio Rank of COCH is 5555Omega Ratio Rank
The Calmar Ratio Rank of COCH is 77Calmar Ratio Rank
The Martin Ratio Rank of COCH is 1414Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Envoy Medical Inc. (COCH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


COCH
Sharpe ratio
The chart of Sharpe ratio for COCH, currently valued at -0.28, compared to the broader market-2.00-1.000.001.002.003.004.00-0.28
Sortino ratio
The chart of Sortino ratio for COCH, currently valued at 0.87, compared to the broader market-4.00-2.000.002.004.006.000.87
Omega ratio
The chart of Omega ratio for COCH, currently valued at 1.12, compared to the broader market0.501.001.502.001.12
Calmar ratio
The chart of Calmar ratio for COCH, currently valued at -0.76, compared to the broader market0.002.004.006.00-0.76
Martin ratio
The chart of Martin ratio for COCH, currently valued at -1.17, compared to the broader market-10.000.0010.0020.0030.00-1.17
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.38, compared to the broader market-2.00-1.000.001.002.003.004.002.38
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.37, compared to the broader market-4.00-2.000.002.004.006.003.37
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.42, compared to the broader market0.501.001.502.001.42
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.94, compared to the broader market0.002.004.006.001.94
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.12, compared to the broader market-10.000.0010.0020.0030.009.12

Sharpe Ratio

The current Envoy Medical Inc. Sharpe ratio is -0.28. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Envoy Medical Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.28
2.38
COCH (Envoy Medical Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Envoy Medical Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-70.38%
-0.09%
COCH (Envoy Medical Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Envoy Medical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Envoy Medical Inc. was 91.33%, occurring on Nov 17, 2023. The portfolio has not yet recovered.

The current Envoy Medical Inc. drawdown is 70.38%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.33%Sep 22, 202341Nov 17, 2023
-2.14%May 25, 20215Jun 1, 2021133Dec 8, 2021138
-1.73%Dec 10, 202134Jan 28, 2022173Oct 6, 2022207
-1.59%Feb 3, 202323Mar 8, 202341May 5, 202364
-1.34%Jul 20, 20238Jul 31, 202335Sep 19, 202343

Volatility

Volatility Chart

The current Envoy Medical Inc. volatility is 39.09%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%140.00%December2024FebruaryMarchAprilMay
39.09%
3.36%
COCH (Envoy Medical Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Envoy Medical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items